PF-Atlas › Mechanisms › LPA1 Antagonist

LPA1 Antagonist in IPF

Mechanism of action · idiopathic pulmonary fibrosis

Overview

LPA1 Antagonist is a therapeutic target in idiopathic pulmonary fibrosis. PF-Atlas tracks 1 drug and 1 clinical trial acting through this mechanism.

Drugs targeting LPA1 Antagonist

Admilparant

Clinical trials

Admilparant — ALOFT-IPF
Medical disclaimer. This is a research summary, not medical advice.